Skip to content

Lidocaine Spray vs Coughing for Pain Relief During Colposcopy

Comparison of Lidocaine Spray With Forced Coughing in Pain Relief During Colposcopy Guided Cervical Biopsy Procedure: A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03100565
Enrollment
96
Registered
2017-04-04
Start date
2016-09-30
Completion date
2018-03-10
Last updated
2018-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colposcopy

Keywords

colposcopy, pain, coughing, anesthetic spray

Brief summary

Cervical cancer is the third most common genital cancer worldwide. The diagnosis of cervical cancer is performed with the cervical biopsy which is guided by the colposcopy. The colposcopy guided cervical biopsy creates pain and several methods have been reported to overcome the pain related with this procedure. Local anesthetic agent injection into the cervix has been studied and found to be effective and also, forced coughing was compared with local anesthetic injection and it is found to be more effective. In fact local injections can create the pain by itself.However no study compared the effect of forced coughing to local anesthetic spray. The study aims to evaluate the comparison of forced coughing with local anesthetic spray with respect to perceived pain during colposcopy guided biopsy.

Interventions

DRUGlocal lidocaine spray

The lidocaine spray will be introduced to the cervix just before the biopsy procedure

The patients will be asked to forced coughing during the biopsy procedure

Sponsors

Yuzuncu Yil University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Masking description

The participants will be blinded to the methods used for pain relief.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patients with age \>18, * Presence of cervix, * Patients who need a diagnostic work up for abnormal cervical smear results.

Exclusion criteria

* Pregnancy, * Presence of already known invasive cancer, * Allergy to anesthetic agents.

Design outcomes

Primary

MeasureTime frameDescription
Pain during procedure evaluated by the 0-10 cm scale of Visual analog scale (VAS) scoring system0-1 minThe perceived pain will be measured during the biopsy procedure. It will be evaluated by the 0-10 cm scale of VAS scoring system. The patient will be asked to rate her pain as 0 corresponds ''no pain'' and 10 to the '' worst pain''

Secondary

MeasureTime frameDescription
Pain at the 30th minutes after the procedure evaluated by the 0-10 cm scale of VAS scoring system30. MinThe perceived pain will be measured after the biopsy procedure (at the 30th min). It will be evaluated by the 0-10 cm scale of VAS scoring system. The patient will be asked to rate her pain as 0 corresponds ''no pain'' and 10 to the '' worst pain''

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026